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to below the present limit? Beyond the applause for higher sensitivitydoi:10.1016/j.jhep.2008.10.004To the Editor:
We read with great interest the article by Togashi et al.
[1] published in a recent issue of Journal of Hepatology.
Authors examined the sensitivity of a radical immunoas-
say they developed to detect hepatitis B surface antigen
(HBsAg) in comparison with real-time polymerase chain
reaction (PCR) detection of hepatitis B virus (HBV)
DNA. With higher sensitivity than EIA and chemilumi-
nescence immunoassay, they concluded that infection
with HBV, including occult HBV, is far more endemic
than suspected previously. Two issues need to be
addressed.
First, although Authors declared their analytical re-
sults appear to be reliable after performing the absorption
test on several low HBsAg-positive cases, the possible
false-positive result might be a considerable issue. Eleven
patients with negative anti-HBc, anti-HBs and HBV
DNA and four patients with negative anti-HBc and
HBV DNA but positive for anti-HBs (assumed to have
receivedHBV vaccination) had lowHBsAg by the radical
immunoassay in Table 3 [1]. The possible false-positive of
the radical immunoassay or the false-negative of the anti-
HBc results have to be considered and further investi-
gated. Besides, of the 34 patients listed in Table 3 [1], the
nine patients with low HBsAg and positive HBV DNA
all had low HBV DNA levels (mean: 1.52 Log IU/mL,
range = 1.0–2.3 Log IU/mL). Currently serum HBV
DNA level P2000 IU/mL is considered signiﬁcantly
associated with the risk of subsequent development of
cirrhosis and hepatocellular carcinoma [2–4] and as one
of the indications for treatment for HBeAg-negative
patients [5,6]. The development of higher sensitivity of
an assay might on one hand improve the conﬁrmatory
ability in diagnosis but also on the other hand result in
an irreconcilable clinical implication. With applausive
sensitivity forHBsAg detection, the conﬁrmation, valida-tion and clinical application of this radical immunoassay
has to be further elucidated.
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